Clinical Trials Browser

NCT04093323 2026-02-25

Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma

Phase 2 Terminated

1 enrolled

Dermatologic

Melanoma

NCT04162873 2025-02-12

Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Phase 2 Terminated

13 enrolled 36 charts

Head & Neck

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms

NCT03643744 2024-12-19

Photodynamic Therapy-Induced Immune Modulation: Part III

Phase 1 Terminated

12 enrolled 9 charts

Dermatologic

Keratosis, Actinic

NCT00151476 2024-09-04

Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients

Terminated

68 enrolled 22 charts

Gastrointestinal

Adenomatous Polyposis Coli

NCT01545141 2023-10-27

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Phase 1/2 Terminated

15 enrolled 9 charts

Gastrointestinal

Neoplasm Metastasis, Recurrence, Colorectal Neoplasms

NCT00665457 2023-09-13

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Phase 2 Terminated

3 enrolled 6 charts

Breast

Breast Neoplasms

NCT02054104 2022-01-26

Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum

Phase 1/2 Terminated

21 enrolled 11 charts

DermatologicSarcoma

Melanoma, Sarcoma, Neoplasm, Residual

NCT00585312 2021-02-21

CHIP

Phase 3 Terminated

106 enrolled 10 charts

Gastrointestinal

Adenomatous Polyposis Coli

NCT00088972 2018-08-10

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

Phase 2 Terminated

8 enrolled 5 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01705106 2018-05-30

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Phase 1 Terminated

21 enrolled 5 charts

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01729923 2018-01-16

ADAPT

Phase 2 Terminated

27 enrolled 10 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00520845 2017-03-20

Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer

Phase 2 Terminated

23 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01555073 2016-07-28

Preemptive Analgesia Following Uterine Artery Embolization

Phase 4 Terminated

23 enrolled 6 charts

Leiomyoma

NCT00198081 2016-02-29

Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)

Phase 2 Terminated

8 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00068770 2015-03-18

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Phase 2 Terminated

35 enrolled 12 charts

CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00527982 2012-12-06

Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer

Phase 2 Terminated

1 enrolled 2 charts

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms

NCT00592319 2012-08-31

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

Phase 2 Terminated

10 enrolled 6 charts

Head & Neck

Laryngeal papillomatosis, Papilloma